Severe heatwave conditions are forecast in NSW in the coming days. Read more
The IRONWOMAN study has started at the Royal Hospital for Women. This is a study for the treatment for iron deficiency anaemia in pregnancy.The study is being undertaken at the Royal Hospital for Women and St George Hospital. Please read the attached document for further information about the study.
If you have any patients who may be eligible and or interested, please contact the research midwife on 0429 557 084 or 0407 498 197 (Monday-Friday 9am-5pm ). Please contact the investigators if you have any questions about the study on Antonia.shand@sydney.edu.au.
Health Referral Forms
ANSC current research opportunities September 2021
About Central and Eastern Sydney PHN
About Membership
Advertise Employment
Allied Health
Check In On Your Wellbeing
Community Member
Contact
Cosprogram
Events
External Events Form
General Practice
General Practice Jobs
GP Psychiatry Support Line
headspace
Home
NewAccess Coaching
News
Privacy
Referral Services
Regional Mental Health and Suicide Prevention Plan
Resources and Links
Sitemap
SWCC Counselling Program
What We Do
Who We Are
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…
